IL6 and depressive symptom measurement: In line with this, in a longitudinal Australian cohort (N = 1,692; 55–85 years), the inflammatory markers interleukin-6 (IL-6) and CRP explained 10.9 and 8.1% of the risk of incident CVD hospitalizations associated with depression, respectively.